 prospect comparison thromboembol stock extern sequenti pneumat compress stock heparin sodium/dihydroergotamin mesyl prevent thromboembol complic urolog surgeri deep venou thrombosi pulmonari emboli patient major urolog oper thromboembol stock extern sequenti pneumat compress stock anticoagul agent heparin sodium dihydroergotamin mesyl risk deep venou thrombosi pulmonari emboli total evalu patient major urolog oper thromboembol stock extern sequenti pneumat compress stock heparin dihydroergotamin prophylaxi deep venou thrombosi pulmonari emboli platelet scan day deep venou thrombosi pulmonari emboli mean patient age year oper neoplast diseas deep venou thrombosi patient thromboembol stock extern sequenti pneumat compress stock heparin dihydroergotamin differ blood loss complic group statist signific treatment group studi trend decreas deep venou thrombosi pulmonari emboli extern sequenti pneumat compress stock heparin dihydroergotamin absenc increas morbid group use modal morbid mortal deep venou thrombosi pulmonari emboli